These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23431892)

  • 21. [Low doses ketamine: antihyperalgesic drug, non-analgesic].
    Richebé P; Rivat C; Rivalan B; Maurette P; Simonnet G
    Ann Fr Anesth Reanim; 2005; 24(11-12):1349-59. PubMed ID: 16115745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of age and sex on ketamine-induced hyperactivity in rats.
    Wilson C; Kercher M; Quinn B; Murphy A; Fiegel C; McLaurin A
    Physiol Behav; 2007 Jun; 91(2-3):202-7. PubMed ID: 17400259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavioral effects associated with chronic ketamine or remacemide exposure in rats.
    Wright LK; Pearson EC; Hammond TG; Paule MG
    Neurotoxicol Teratol; 2007; 29(3):348-59. PubMed ID: 17291718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors.
    Orser BA; Pennefather PS; MacDonald JF
    Anesthesiology; 1997 Apr; 86(4):903-17. PubMed ID: 9105235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The improvement of the anti-hyperalgesic effect of ketamine and of its isomers by the administration of ifenprodil.
    Rondon ES; Vieira AS; Valadão CA; Parada CA
    Eur J Pharmacol; 2010 Nov; 647(1-3):84-9. PubMed ID: 20826141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The mechanisms of action of ketamine].
    Tarakanov AV; Khloponin DP; Makliakov IuS
    Eksp Klin Farmakol; 1996; 59(6):56-61. PubMed ID: 9181878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnesium deficiency increases ketamine sensitivity in rats.
    Orser B; Smith D; Henderson S; Gelb A
    Can J Anaesth; 1997 Aug; 44(8):883-90. PubMed ID: 9260017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies with ketamine and alfentanil following Freund's complete adjuvant-induced inflammation in rats.
    Edwards SR; Mather LE; Smith MT
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):414-20. PubMed ID: 17439409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-methyl-D-aspartate glutamate receptor antagonists and the promise of rapid-acting antidepressants.
    Krystal JH
    Arch Gen Psychiatry; 2010 Nov; 67(11):1110-1. PubMed ID: 21041611
    [No Abstract]   [Full Text] [Related]  

  • 30. NMDA receptor blockade: from the laboratory to clinical application.
    Ben-David B
    Anesth Analg; 2000 Oct; 91(4):1042-3. PubMed ID: 11004081
    [No Abstract]   [Full Text] [Related]  

  • 31. Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways.
    Chizh BA
    J Psychopharmacol; 2007 May; 21(3):259-71. PubMed ID: 17591654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological Arguments Against the Use of Ketamine in Nonmedical Settings.
    Green DJ; Masters JC;
    J Clin Pharmacol; 2022 Jan; 62(1):7-9. PubMed ID: 34643961
    [No Abstract]   [Full Text] [Related]  

  • 33.
    Chen Y; Xu W; Yuan Y; Chen H; Zheng S; He Y; Luo T
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigational NMDA receptor modulators for depression.
    Szewczyk B; Pałucha-Poniewiera A; Poleszak E; Pilc A; Nowak G
    Expert Opin Investig Drugs; 2012 Jan; 21(1):91-102. PubMed ID: 22097925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fast-spiking interneurons and gamma oscillations may be involved in the antidepressant effects of ketamine.
    Zhou ZQ; Zhang GF; Li XM; Yang C; Yang JJ
    Med Hypotheses; 2012 Jul; 79(1):85-6. PubMed ID: 22543075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronopharmacological studies of ketamine in normal and NMDA epsilon1 receptor knockout mice.
    Sato Y; Kobayashi E; Hakamata Y; Kobahashi M; Wainai T; Murayama T; Mishina M; Seo N
    Br J Anaesth; 2004 Jun; 92(6):859-64. PubMed ID: 15064251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Elucidation of anesthetic and analgesic effects of ketamine using NMDA receptor epsilon 1 subunit-deficient mice].
    Yamakura T; Petrenko AB; Baba Y; Sakimura K
    Masui; 2006 Nov; 55 Suppl():S141-4. PubMed ID: 17458131
    [No Abstract]   [Full Text] [Related]  

  • 38. Ketamine a dissociative anesthetic: Neurobiology and biomolecular exploration in depression.
    Liu GL; Cui YF; Lu C; Zhao P
    Chem Biol Interact; 2020 Mar; 319():109006. PubMed ID: 32084352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of ketamine in complex regional pain syndrome: possible mechanisms.
    Schwartzman RJ; Alexander GM; Grothusen JR
    Expert Rev Neurother; 2011 May; 11(5):719-34. PubMed ID: 21539489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ketamine's dose related multiple mechanisms of actions: Dissociative anesthetic to rapid antidepressant.
    Lavender E; Hirasawa-Fujita M; Domino EF
    Behav Brain Res; 2020 Jul; 390():112631. PubMed ID: 32437885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.